ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,055 | -27.1% | 5,002 | 0.0% | 0.00% | – |
| Q2 2023 | $17,907 | +62.6% | 5,002 | -1.0% | 0.00% | – |
| Q1 2023 | $11,013 | -81.9% | 5,052 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $60,776 | +84.2% | 5,052 | 0.0% | 0.00% | – |
| Q3 2022 | $33,000 | +43.5% | 5,052 | 0.0% | 0.00% | – |
| Q2 2022 | $23,000 | -47.7% | 5,052 | 0.0% | 0.00% | – |
| Q1 2022 | $44,000 | -38.9% | 5,052 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $72,000 | -34.5% | 5,052 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $110,000 | – | 5,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |